Professor Thozhukat Sathyapalan T.Sathyapalan@hull.ac.uk
Professor of Diabetes, Endocrinology and Metabolism
CRN funding - HYPER AID
People Involved
Project Description
0.5 funding for Dana Schofield for 8 months from 01/08/2022 - 31/03/2023
Support a concerted effort to maximise recruitment to this Diabetes study in Yorkshire and Humber. Although recruitment target has been met, global recruitment (nationally) is still low. There is a potential to over-recruit and support this study nationally
| Status | Project Complete |
|---|---|
| Value | £6,933.00 |
| Project Dates | Aug 1, 2022 - Mar 31, 2023 |
| Partner Organisations | Hull University Teaching Hospitals NHS Trust |
You might also like
Esperion ETC 1002 Study Nov 1, 2016 - Mar 31, 2019
PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment Nov 1, 2016 - Oct 31, 2019
Primary objective:
To compare the effect of once-daily dosing of 14 mg oral semaglutide versus placebo, both in combination with metformin and/or sulfonylurea, basal insulin alone or metformin in combination with basal insulin on glycaemic control i...
Read More about PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment.
IVF Study 1: Does Insulin or Endocrine Disruptor levels affect fertility? Jan 1, 2014 - Dec 31, 2018